Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

9.830 +0.220 (+2.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,857,305
Open 9.900
Bid (Size) 9.420 (100)
Ask (Size) 10.30 (200)
Prev. Close 9.610
Today's Range 9.300 - 9.900
52wk Range 3.970 - 18.67
Shares Outstanding 93,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy

Performance

YTD
-41.5%
-41.5%
1 Month
-32.9%
-32.9%
3 Month
-33.5%
-33.5%
6 Month
-4.7%
-4.7%
1 Year
-3.9%
-3.9%

More News

Read More
News headline image
Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
News headline image
Fortrea (FTRE) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Fortrea Holdings Inc (NASDAQ:FTRE) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
Via Chartmill
News headline image
Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Via StockStory
News headline image
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Earnings To Watch: Fortrea (FTRE) Reports Q4 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
Via StockStory
Topics Government World Trade
News headline image
1 Russell 2000 Stock to Target This Week and 2 That Underwhelm
Via StockStory
News headline image
3 Reasons to Sell FTRE and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
News headline image
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
2 Unprofitable Stocks with Promising Prospects and 1 We Turn Down
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Initial Public Offering Supply Chain
News headline image
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
3 Small-Cap Stocks Walking a Fine Line
Via StockStory
News headline image
3 Unpopular Stocks We Steer Clear Of
Via StockStory
News headline image
3 Inflated Stocks with Open Questions
Via StockStory
News headline image
3 Stocks Under $50 Walking a Fine Line
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Up Today
Via StockStory
Topics Initial Public Offering
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
Via StockStory
Topics Initial Public Offering
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire

Frequently Asked Questions

Is Fortrea Holdings Inc. - Common Stock publicly traded?
Yes, Fortrea Holdings Inc. - Common Stock is publicly traded.
What exchange does Fortrea Holdings Inc. - Common Stock trade on?
Fortrea Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fortrea Holdings Inc. - Common Stock?
The ticker symbol for Fortrea Holdings Inc. - Common Stock is FTRE on the Nasdaq Stock Market
What is the current price of Fortrea Holdings Inc. - Common Stock?
The current price of Fortrea Holdings Inc. - Common Stock is 9.830
When was Fortrea Holdings Inc. - Common Stock last traded?
The last trade of Fortrea Holdings Inc. - Common Stock was at 03/09/26 04:00 PM ET
What is the market capitalization of Fortrea Holdings Inc. - Common Stock?
The market capitalization of Fortrea Holdings Inc. - Common Stock is 919.11M
How many shares of Fortrea Holdings Inc. - Common Stock are outstanding?
Fortrea Holdings Inc. - Common Stock has 919M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.